BioFire Diagnostics Receives FDA Clearance for FilmArray 2.0 System | GenomeWeb

NEW YORK (GenomeWeb) – BioMérieux today announced that its subsidiary BioFire Diagnostics has received US Food and Drug Administration clearance and CE-IVD marking for the FilmArray 2.0 system.

The PCR-based platform has higher throughput, processing up to 175 samples per day, and a smaller footprint, the firm said in a statement. It will be commercially available by the end of March.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.